Cheryl Renz
ORCID: 0000-0002-7051-1653
· 3 papers in corpus
other
2026
INTRODUCTION: Casirivimab/imdevimab (CAS/IMD) comprises two monoclonal antibodies that neutralize SARS-CoV-2. Pregnant individuals were excluded from initial trials, limiting safety data. METHODS: The COVID-19 International Drug Pregnancy …
other
2019
OBJECTIVES: To quantify patient preferences for endometriosis-associated pain treatments and risk tolerance in exchange for pain reduction and to explore whether preferences vary on the basis of patient characteristics. METHODS: US women w…
2018